Carbon dots as dual inhibitors of tau and amyloid-beta aggregation for the treatment of Alzheimer's disease

刚果红 细胞毒性 淀粉样蛋白(真菌学) 化学 老年斑 β淀粉样蛋白 硫黄素 生物物理学 血脑屏障 生物相容性 生物化学 纳米载体 药理学 药品 阿尔茨海默病 生物 医学 病理 疾病 神经科学 体外 中枢神经系统 无机化学 肽 有机化学 吸附
作者
Wei Zhang,Nathan Smith,Yiqun Zhou,Caitlin M. McGee,Mattia Bartoli,Shiwei Fu,Jiuyan Chen,Justin B. Domena,Annu Joji,Hannah Burr,Guohua Lv,Emel Kirbas Cilingir,Susanna Bedendo,Matteo L. Claure,Alberto Tagliaferro,David Eliezer,Eduardo A. Véliz,Fuwu Zhang,Chunyu Wang,Roger M. Leblanc
出处
期刊:Acta Biomaterialia [Elsevier BV]
卷期号:183: 341-355 被引量:12
标识
DOI:10.1016/j.actbio.2024.06.001
摘要

Alzheimer's disease (AD) is the most common form of senile dementia, presenting a significant challenge for the development of effective treatments. AD is characterized by extracellular amyloid plaques and intraneuronal neurofibrillary tangles. Therefore, targeting both hallmarks through inhibition of amyloid beta (Aβ) and tau aggregation presents a promising approach for drug development. Carbon dots (CD), with their high biocompatibility, minimal cytotoxicity, and blood-brain barrier (BBB) permeability, have emerged as promising drug nanocarriers. Congo red, an azo dye, has gathered significant attention for inhibiting amyloid-beta and tau aggregation. However, Congo red's inability to cross the BBB limits its potential to be used as a drug candidate for central nervous system (CNS) diseases. Furthermore, current studies only focus on using Congo red to target single disease hallmarks, without investigating dual inhibition capabilities. In this study, we synthesized Congo red-derived CD (CRCD) by using Congo red and citric acid as precursors, resulting in three variants, CRCD1, CRCD2 and CRCD3, based on different mass ratios of precursors. CRCD2 and CRCD3 exhibited sustained low cytotoxicity, and CRCD3 demonstrated the ability to traverse the BBB in a zebrafish model. Moreover, thioflavin T (ThT) aggregation assays and AFM imaging revealed CRCD as potent inhibitors against both tau and Aβ aggregation. Notably, CRCD1 emerged as the most robust inhibitor, displaying IC50 values of 0.2 ± 0.1 and 2.1 ± 0.5 μg/mL against tau and Aβ aggregation, respectively. Our findings underscore the dual inhibitory role of CRCD against tau and Aβ aggregation, showcasing effective BBB penetration and positioning CRCD as potential nanodrugs and nanocarriers for the CNS. Hence, CRCD-based compounds represent a promising candidate in the realm of multi-functional AD therapeutics, offering an innovative formulation component for future developments in this area. This article reports Congo red-derived carbon dots (CRCD) as dual inhibitors of tau and amyloid-beta (Aβ) aggregation for the treatment of Alzheimer's disease (AD). The CRCD are biocompatible and show strong fluorescence, high stability, the ability to cross the blood-brain barrier, and the function of addressing two major pathological features of AD.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
YitingW发布了新的文献求助10
刚刚
刚刚
研友_nVj3yn发布了新的文献求助10
刚刚
斯文败类的应助被chuhan采纳,获得10
刚刚
gela发布了新的文献求助10
1秒前
bkagyin的应助被我爱玩原神采纳,获得10
1秒前
汉堡包的应助被Ma采纳,获得10
1秒前
Ava的应助被wu采纳,获得10
1秒前
李元发布了新的文献求助10
1秒前
zzl发布了新的文献求助10
2秒前
Maestro_S的应助被职克琪采纳,获得10
2秒前
隐形曼青的应助被职克琪采纳,获得10
2秒前
2秒前
zxy发布了新的文献求助10
2秒前
甜美的兔子完成签到,获得积分10
3秒前
3秒前
accepted完成签到,获得积分10
3秒前
传奇3的应助被愤怒的水壶采纳,获得10
3秒前
SciGPT的应助被lawliet采纳,获得10
3秒前
小零完成签到,获得积分10
3秒前
Maestro_S的应助被h11采纳,获得10
3秒前
jhlllllll发布了新的文献求助10
3秒前
董文强发布了新的文献求助10
4秒前
4秒前
4秒前
清风明月发布了新的文献求助10
4秒前
迷了路的猫完成签到,获得积分10
5秒前
5秒前
jonghuang发布了新的文献求助10
8秒前
赘婿的应助被window1000采纳,获得10
8秒前
贤君发布了新的文献求助10
8秒前
9秒前
9秒前
cz完成签到,获得积分10
10秒前
闪闪的灵发布了新的文献求助10
10秒前
NexusExplorer的应助被果冻采纳,获得10
11秒前
拼搏的帽子完成签到 ,获得积分10
11秒前
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8164445
求助须知:如何正确求助?哪些是违规求助? 9558283
关于积分的说明 21744871
捐赠科研通 7754979
什么是DOI,文献DOI怎么找? 3428582
关于科研通互助平台的介绍 2553119
邀请新用户注册赠送积分活动 2473142